Pds Planning, Inc Scynexis Inc Transaction History
Pds Planning, Inc
- $1.1 Billion
- Q3 2024
A detailed history of Pds Planning, Inc transactions in Scynexis Inc stock. As of the latest transaction made, Pds Planning, Inc holds 15,000 shares of SCYX stock, worth $20,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,000
Previous 15,000
-0.0%
Holding current value
$20,250
Previous $30,000
26.67%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SCYX
# of Institutions
53Shares Held
14.4MCall Options Held
34KPut Options Held
5K-
Federated Hermes, Inc. Pittsburgh, PA4.21MShares$5.69 Million0.02% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY2.24MShares$3.02 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.69MShares$2.28 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.45MShares$1.96 Million0.14% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC556KShares$749,9990.7% of portfolio
About SCYNEXIS INC
- Ticker SCYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 32,651,800
- Market Cap $44.1M
- Description
- SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...